Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Local Neoplasm Recurrence

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Local Neoplasm Recurrence in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Arora, G; Axtell, AL; Bardeesy, N; Caravan, P; Chawla, A; Chen, YI; Deshpande, V; Erstad, DJ; Farrar, CT; Ferreira, DS; Ferrone, CR; Fuchs, BC; Ghoshal, S; Graham-O'Regan, KA; Humblet, V; Jones, C; Jordan, VC; Kontos, F; Lanuti, M; Li, S; Michelakos, T; Qadan, M; Rotile, NJ; Sojoodi, M; Tanabe, KK; Taylor, MS1
Nidecker, A1
Contesso, G; Gilles, R; Guinebretière, JM; Lesnik, A; Masselot, J; Sarrazin, D; Shapeero, LG; Vanel, D1
Asselain, B; Campana, F; Dao, TH; Fourquet, A; Laurent, M; Rahmouni, A1
Arriagada, R; Bittoun, J; Contesso, G; Gilles, R; Guinebretière, JM; Petit, JY; Rochard, F; Tardivon, AA; Thiollier, S; Vanel, D1

Other Studies

5 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Local Neoplasm Recurrence

ArticleYear
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 09-15, Volume: 26, Issue:18

    Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Chemoradiotherapy, Adjuvant; Collagen; Disease-Free Survival; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heterocyclic Compounds; Humans; Irinotecan; Leucovorin; Magnetic Resonance Imaging; Male; Mice; Middle Aged; Molecular Imaging; Molecular Probes; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organometallic Compounds; Oxaliplatin; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Xenograft Model Antitumor Assays

2020
Recurrent bone neoplasm and spiral bladder pattern on pelvic MRI.
    Journal belge de radiologie, 1993, Volume: 76, Issue:6

    Topics: Bone Neoplasms; Contrast Media; Gadolinium; Hemipelvectomy; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pelvic Neoplasms; Urinary Bladder

1993
Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients.
    Radiology, 1993, Volume: 188, Issue:2

    Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Subtraction Technique

1993
Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging.
    Radiology, 1993, Volume: 187, Issue:3

    Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibrosis; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Radiation Injuries; ROC Curve

1993
[Diagnosis of local breast cancer recurrences by magnetic resonance imaging].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1995, Volume: 24, Issue:8

    Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity

1995